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Abstract
OBJECTIVE: To study the daily administration
times of Canhuang tablet (CHT) for treating jaun-
dice in rats based on a pharmacodynamic/ pharma-
cokinetic model.
METHODS: Rats were modeled by 4% 1-Naphthyl-
isothiocyanate (75 mg/kg, p.o.). After 48 h, CHT was
given (p.o.) at 0.75 g/kg once a day, 0.375 g/kg
twice a day, and 0.25 g/kg three times a day. Blood
was collected from the orbital sinus at different in-
tervals. Levels of liver enzymes and bilirubin were
detected using these blood samples. Bile was col-
lected and determined after the first administra-
tion of CHT. High-performance liquid chromatogra-
phy was used to determine the concentration of
berberine in bile simultaneously. Time-effect and
time-dose curves were then obtained.
RESULTS: Compared with rats taking CHT twice
and three times a day, the total amount of bile with-
in 10 h of rats taking CHT once a day were 1.32-
and 1.47-fold higher, respectively. There was good
consistency between the pharmacokinetics of ber-
berine and the pharmacodynamics of the effect
on liver enzymes and bilirubin in vivo. The pharma-
cokinetic analyses showed that rats administered
CHT once daily maintained a higher concentration
of berberine in bile for a longer period than rats ad-
ministered CHT two- and three-times daily.
CONCLUSION: In jaundiced rats, taking CHT once a
day is better than taking CHT twice or three times a
day. These data may provide a reference for the clin-
ical application of CHT.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
The method of administration of a traditional Chinese
medicine (TCM) has a crucial role in its therapeutic ef-
fect. If the TCM is administered in an inappropriate
way, it may have a suboptimal effect even though its
method of preparation, quality and efficacy are opti-
mal. The number of times a TCM is administered in a
day is important because it has a direct impact upon its
safety and efficacy.1
For a long time, the number of times a day a TCM was
administered was based on experience, and a regimen
of three-times daily commonly used. Currently, admin-
istration of TCMs in the hospital setting is twice daily.
However, we do not know which regimen is the most
scientific and effective.
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To answer this question, we based our research on phar-
macodynamic-pharmacokinetic studies.2 Previously, we
studied the administration time of TCMs for the treat-
ment of jaundice using a decoction based on rhubarb
and yinchenhao.3,4 In those studies, the daily adminis-
tration times of Canhuang tablet (CHT) for the treat-
ment of jaundice were investigated. This was done to
evaluate which regimen was the most scientific and ef-
fective based on PD-PK as well as to provide a basis for
the clinical application of CHT.
Jaundice leads to partial or complete blockage of bile
flow.3 The main features are a reduction in the amount
of conjugated bilirubin excreted by the intestine. This
phenomenon makes the color of stools lighter and that
of urine darker. It is accompanied by an increase in the
serum concentration of total bilirubin (TBIL), alkaline
phosphatase (ALP), alanine aminotransferase (ALT)
and aspartate aminotransferase (AST). In the present
study, 1-Naphthylisothiocyanate (ANIT) was used to
induce intrahepatic cholestasis (i.e., jaundice) in rats
because the biochemical and pathological changes of
ANIT-induced liver injury of rats are similar to the le-
sions caused by jaundice in humans.
CHT is composed of Huanglian (Rhizoma Coptidis),
Qingdai (Indigo Naturalis), Baifan (Alumen) and Yujin
(Radix Curcumae Wenyujin). It is used to treat the resid-
ual jaundice induced by chronic hepatitis.5,6 Huanglian
(Rhizoma Coptidis) is a monarch drug. It has the effect
of clearing heat, eliminating dampness, reducing fire,
detoxication, and withdrawing jaundice. Berberine is
one of the main alkaloids of Huanglian (Rhizoma Cop-
tidis). It has a hepatoprotective effect, but has a low
concentration in plasma and a high concentration in
bile.7-9 In the present study, we determined the concen-
tration of berberine in bile at pre-determined time in-
tervals and investigated the pharmacodynamics of
CHT to ascertain the daily administration times of
CHT.
MATERIALS ANDMETHODS
Ethical approval of the study protocol
The study protocol was approved by the Animal Care
and Use Committee of the 302 Hospital of the Peo-
ple's Liberation Army (Beijing, China).
Main chemicals
Berberine standard was purchased from the National
Institute for the Control of Pharmaceutical and Biolog-
ical Products (Beijing, China). ANIT (95% purity)
was from Sigma-Aldrich (Steinheim, Germany). Assay
kits for determination of the levels of liver enzymes
were purchased from Shenzhen Mindray Medical Inter-
national (Shenzhen, China). Urethane was obtained
from Sinopharm Chemical Reagents (Shanghai, Chi-
na). Olive oil was purchased from Acros (Beijing, Chi-
na). Methanol of high-performance liquid chromatog-
raphy (HPLC) grade was purchased from Promptar
(Elk Grove, CA, USA). CHT was prepared by the
Pharmaceutical Laboratory of 302 Military Hospital of
the People's Liberation Army.
Main apparatus
Apparatus included an automatic biochemical analyzer
(BS-300; Shenzhen Mindray International, Beijing,
China), a HPLC system (LC-20AT; Shimadzu, Kyoto,
Japan), high-speed desktop centrifuge (TGL-16GB;
Guangzhou Huarui Chemical Instruments, Shanghai,
China), and a vortex mixer (MS3; IKA®, Staufen, Ger-
many).
Experimental animals
Wistar rats of specific pathogen-free (SPF) grade
(200-220 g) were supplied by the Military Medical Sci-
ence Academy of the People's Liberation Army (certifi-
cate number: SCXK-(army) 2007-004). They were
housed at room temperature (24 ± 2)℃ with a 12 h
light-dark cycle with food and water available ad libi-
tum. Rats were fasted for 12 h with free access to water
before experiments. Rats were killed by cervical disloca-
tion at the end of the experiment.
Animal model and dose regimen
Eighty Wistar rats of SPF grade were used in the phar-
macodynamics experiment. They were divided random-
ly into five groups of 16. Group Ⅰ was the normal
control group (0.9% sodium chloride, i.g.). Group Ⅱ
was the model group (0.9% sodium chloride, i.g.).
Group Ⅲ was one administration per day (0.75 g/kg
at 9:00). Group Ⅳ was two administrations per day
(0.375 g/kg at 9:00 and 13:00). Group Ⅴ was three
administrations per day (0.25 g/kg at 9:00, 13:00 and
17:00). Rats in groups Ⅱ-Ⅴ were infused with 4%
ANIT olive oil solution (75 mg/kg, i.g.) to establish a
model of jaundice.10 Forty-eight hours after modeling,
0.9% sodium chloride was drenched to the rats of
group Ⅱ. Rats of groups Ⅲ-Ⅴ were administered
CHT (p.o.) according to the dose regimen described
above.
Analyses of biochemical markers in serum
Eight rats in each group were used in this experiment.
Blood samples (0.5 mL) from rats were collected in
tubes without decoagulant via the orbit vein pre-admin-
istration (0 h) and at 0.083, 0.25, 0.5, 1, 2, 4, 6, 10, 12
and 24 h after the first administration of CHT sample.
Blood samples were centrifuged immediately at 8000
rpm for 10 min at 4 ℃ to yield serum. Serum samples
(100 μL) were transferred into new tubes and diluted
with 400 μL 0.9% sodium chloride. Serum levels of
ALT, AST, TBIL, direct bilirubin (DBIL) and ALP
were measured using the automatic biochemical analyz-
er according to the instructions given in the assay kits.
Bile collection and sample pretreatment
The other 8 rats in each group were used in a bili-
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ary-drainage experiment following methods described
previously.11 After the first administration of CHT, rats
were anesthetized [20% urethane (10 mL/kg), i.p.].
They were then placed in a thermostatic chamber to
maintain normal body temperature. The abdominal ar-
ea was shaved and cleaned. A transverse midline inci-
sion of length 2 cm was then made. The common bile
duct was separated carefully. Bile was drained into
tubes by insertion of tubing into the bile duct. The bile
flow per hour as well as the total amount of bile was re-
corded. Bile samples were collected every hour and
stored at﹣80℃ for determination of berberine.
Determination of berberine
Frozen bile samples were thawed at room temperature.
A 100-µL aliquot of the bile sample was put into a
1.5-mL centrifuge tube and mixed with 300 µL metha-
nol under vortex mixing for 1 min to precipitate pro-
teins. After centrifugation at 8000 rpm for 10 min at
4℃, the supernatant was transferred to a clean tube and
evaporated to dryness under a gentle stream of nitrogen
gas at 40℃ in a water bath. The residue was reconstitut-
ed with 100 µL absolute methanol under vortex mixing
for 5 min. The suspension was centrifuged at 8000 rpm
for 10 min. Then, 20 µL of supernatant was injected di-
rectly into the HPLC system for analyses.
The concentration of berberine in bile was measured
by a HPLC method with a Prominence liquid chroma-
tography system comprising a quaternary pump
(LC-20AT), a diode array detector (SPD-M20A), an
auto sampler (SIL-20A), a degassing unit (DGU-
20A5R) and Shimadzu CBM-20A station for data anal-
yses. Analyses were undertaken on an AlltimaTM C18
column (250 mm × 4.6 mm, 5 μm; Alltech, Stam-
ford, UK), protected by an Alltima C18 guard col-
umn (20 mm× 4 mm, 5 μm). The mobile phase was a
mixture of acetonitrile and 0.05 mol/L KH2PO4 solu-
tion containing 0.4% (w/v) sodium lauryl sulfate
(phosphoric acid was added to adjust the pH to 4) (55∶
45, v/v) with a flow rate of 1.0 mL/min. The effluent
was monitored for UV absorption at 345 nm.
Statistical analyses
Pharmacokinetic parameters were obtained from the
bile concentration-time curves. Area under the curve
to the last measurable concentration (AUC0→t) was cal-
culated using the linear trapezoidal rule. Statistical anal-
yses were done using one-way analysis of variance with
SPSS ver 17.0 (SPSS, Chicago, IL, USA), followed by
the least significant difference post hoc test. Results are
the mean ± standard deviation ( xˉ ± s). Differences be-
tween experimental groups were considered significant
at P < 0.05.
RESULTS
Total amount of bile
The total amount of bile in group Ⅱ rats was signifi-
cantly lower than that of groupⅠ rats (P < 0.05), sug-
gesting that the model of jaundice had been developed
successfully. The total amount of bile of rats in groupⅢ was significantly greater than that of rats of the
model group (P < 0.05). This finding suggested that
administration of CHT (0.75 g/kg) once a day could
significantly increase the total amount of bile of jaun-
diced rats within 10 h. There were no significant differ-
ence between the control group and groups Ⅱ,Ⅳ andⅤ. Within 10 h, the total amount of bile of rats in
group Ⅲ was 1.32, and 1.47-fold higher than that of
the groupsⅣandⅤ (Figure 1).
Hourly rate of bile flow
A tendency of increasing hourly rates of bile flow in
the first 2 h followed by decreasing hourly rates of bile
flow was observed in each group. There was a signifi-
cant difference between groups Ⅱ and Ⅲ (P < 0.05).
The hourly rate of bile flow was increased both in
groupsⅣ andⅤ compared with that of groupⅡ, but
this difference was not significant (P > 0.05) (Figure 2).
Changes in bilirubin levels in whole blood
Levels of TBIL and DBIL in group Ⅱ were increased
significantly and maintained at a high level within 24 h
after being modeled with ANIT compared with that of
group Ⅰ (P < 0.01). Moreover, levels of TBIL and
DBIL in group Ⅱ continued to increase with increas-
ing time. Levels of TBIL and DBIL of groupsⅢ-Ⅴ al-
so continued to increase, but were reduced significant-
ly (P < 0.05) compared with those of group Ⅱ, and
considerable variability was observed among the three
groups. Levels of TBIL and DBIL in group Ⅲ de-
creased rapidly to 69.31% and 67.83% at 24 h, respec-
tively (Figures 3, 4).
Changes in liver function
Levels of ALT, AST and ALP can be employed as bio-
chemical markers of liver function. They can also re-
flect the pharmacodynamic index when CHT is given
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Figure 1 Total amount of bile in the five groups ( xˉ ± s, n = 8)Ⅰ: normal control group (0.9% sodium chloride, i.g.); Ⅱ:
model group (0.9% sodium chloride, i.g.);Ⅲ: Canhuang tab-
let (0.75 g/kg, one administration per day); Ⅳ: Canhuang
tablet (0.375 g/kg, two administrations per day); Ⅴ: Can-
huang tablet (0.25 g/kg, three administrations per day).
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at different times in rats. Levels of ALT, AST and ALP
in group Ⅱ were maintained at a higher level than
those of group Ⅰ, which suggested that the liver was
injured to some extent. AST levels in groups Ⅱ-Ⅴ
continued to increase with increasing time, but the
AST levels of groups Ⅲ-Ⅴ were significantly lower
than those of group Ⅰ within 24 h (P < 0.05). There
was no significant difference among the three groups
(P > 0.05) (Figure 5). ALT levels of groups Ⅱ, Ⅳ andⅤ showed no significant difference in the first 8 h, but
group Ⅲ showed an obvious reduction compared with
those of groupⅡ. ALT levels of groupsⅢ-Ⅴ were sig-
nificantly lower than those of group Ⅱ at 24 h (P <
0.05) (Figure 6). ALP levels of groups Ⅲ-Ⅴ were sig-
nificantly lower than those of group Ⅱ within 24 h,
and there was no significant difference between groupsⅢ andⅣ (P > 0.05). However, ALP levels of groupⅤ
were reduced significantly compared to those of groupsⅢ andⅣ (P < 0.05) (Figure 7).
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Figure 2 Hourly flow rate of bile in the five groups ( xˉ ± s, n=
8)Ⅰ: normal control group (0.9% sodium chloride, i.g.); Ⅱ:
model group (0.9% sodium chloride, i.g.); Ⅲ: Canhuang
tablet (0.75 g/kg, one administration per day); Ⅳ: Can-
huang tablet (0.375 g/kg, two administrations per day);Ⅴ: Canhuang tablet (0.25 g/kg, three administrations per
day).
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Figure 6 Levels of alanine aminotransferase in the five
groups ( xˉ ± s, n=8)Ⅰ: normal control group (0.9% sodium chloride, i.g.); Ⅱ:
model group (0.9% sodium chloride, i.g.);Ⅲ: Canhuang tab-
let (0.75 g/kg, one administration per day); Ⅳ: Canhuang
tablet (0.375 g/kg, two administrations per day); Ⅴ: Can-
huang tablet (0.25 g/kg, three administrations per day).
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Figure 5 Levels of aspartate aminotransferase in the five
groups ( xˉ ± s, n = 8)Ⅰ: normal control group (0.9% sodium chloride, i.g.); Ⅱ:
model group (0.9% sodium chloride, i.g.); Ⅲ: Canhuang
tablet (0.75 g/kg, one administration per day); Ⅳ: Can-
huang tablet (0.375 g/kg, two administrations per day);Ⅴ: Canhuang tablet (0.25 g/kg, three administrations per
day).
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Figure 4 Levels of total bilirubin in the five groups ( xˉ ± s,
n = 8)Ⅰ: normal control group (0.9% sodium chloride, i.g.); Ⅱ:
model group (0.9% sodium chloride, i.g.);Ⅲ: Canhuang tab-
let (0.75 g/kg, one administration per day); Ⅳ: Canhuang
tablet (0.375 g/kg, two administrations per day); Ⅴ: Can-
huang tablet (0.25 g/kg, three administrations per day).
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Figure 3 Levels of direct bilirubin in the five groups ( xˉ ± s,
n = 8)Ⅰ: normal control group (0.9% sodium chloride, i.g.); Ⅱ:
model group (0.9% sodium chloride, i.g.);Ⅲ: Canhuang tab-
let (0.75 g/kg, one administration per day); Ⅳ: Canhuang
tablet (0.375 g/kg, two administrations per day); Ⅴ: Can-
huang tablet (0.25 g/kg, three administrations per day).
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Pharmacokinetics of berberine in bile
Berberine concentrations in bile in rats were measured
every hour after CHT (0.75 g/kg) was given once a
day, 0.375 g/kg given twice a day, and 0.25 g/kg given
three times a day. The mean bile concentration-time
curves showed a high concentration of berberine in
bile. According to the dosing regimen, the concentra-
tion of berberine in bile peaked at 4 h, increased rapid-
ly, and then maintained a high level until 24 h (Figure
8). The AUC0→t of groupsⅢ-Ⅴ was (137 ± 18), (81 ±
17) and (75 ± 15) mg·L – 1·h – 1, respectively. The
AUC0→t of group Ⅲ was higher than that of groups Ⅲ
and Ⅳ (P < 0.05). The pharmacokinetic analyses
showed that rats administered CHT once daily main-
tained a higher concentration of berberine in bile for a
longer period than rats administered CHT two- and
three-times daily.
DISCUSSION
In recent years, several studies on TCMs have been car-
ried out, but most have focused on active substances,
pharmacological effects, and the mechanism of action
of the active substances. These studies have been com-
prehensive, but a seemingly unbridgeable gulf between
laboratory studies and clinic application remain.
The rapidly developing field of translational medicine
emphasizes close integration of basic research and clini-
cal application with the aim of optimizing patient care
and preventative measures that could extend beyond
healthcare services.12 This new model of medical re-
search advocates that scientists should regard patients
as "the subject". Converting appropriate biological dis-
coveries into drugs and medical devices can be used for
the treatment of patients. The administration times of
TCMs are closely related to their clinical application,
making them crucial issues that cannot be ignored.
Such studies not only supplement the basic theory of
Chinese folk medicine, they also aid modernization of
such natural agents.13,14
In the present study, the effects of CHT were investi-
gated in rats in which jaundice had been induced by
ANIT. ANIT can damage cells in the liver and bile
duct, causing considerable increases in the levels of bili-
rubin and transaminases in blood.15-17 The present study
showed that CHT could significantly promote bile se-
cretion and reduce the elevated serum levels of ALT,
AST and ALP induced by ANIT. Hence, CHT ap-
peared to reverse the pathological features of jaundice.
We investigated the daily administration times of
CHT in the treatment of jaundice. Pharmacodynamic
results showed that the elevated serum levels of ALT,
AST and ALP induced by ANIT were reduced differ-
ently according to the different times of administration
of CHT. Taking CHT once a day could significantly re-
duce the elevated serum levels of ALT, AST and ALP
compared with that of taking CHT twice or three
times a day. The concentration of berberine in bile was
also determined due to its poor gastrointestinal absorp-
tion and low concentration in plasma.18 Pharmacoki-
netic results showed different concentrations of berber-
ine in bile caused by different administration times of
CHT. The AUC0→t of rats taking CHT once a day was
higher than that of rats taking CHT twice and three
times a day.
In summary, taking CHT once a day for treatment of
experimentally induced jaundice in rats appeared to be
the best option according to time-effect and time-con-
centration relationships. These data may provide refer-
ence values for the clinical application of CHT.
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